FMEDvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with FMED, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 11/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FMED ETF 2 | -4.35%– | +7.81%– | +14.76%– | +19.85%– | +48.91%– | n/a– |
| Flows | FMED ETF 2 | -$3M– | -$3M– | -$20M– | -$18M– | -$15M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FMED ETF 2 | +31.58%– | +24.11%– | +20.23%– | n/a– |
| Max drawdown | FMED ETF 2 | -7.63%– | -17.78%– | -19.20%– | n/a– |
| Max drawdown duration | FMED ETF 2 | 69d– | 212d– | 267d– | n/a– |
Trading data
FMED | ETF 2 | |
Last sale | – | |
| Previous close 11/04/2026 | – | |
| Consolidated volume 11/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
FMED | ETF 2 | |
|---|---|---|
| Last price | – | – |
| 1D performance | – | – |
| AuM | $47.38 M | – |
| E/R | 0.5% | – |
Characteristics
FMED | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Fidelity | – |
| Benchmark | - | – |
| N° of holdings | 71 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FMED
USA
84.97%
Other
15.03%
ETF 2
Sectors
FMED
Healthcare
99.49%
Other
0.51%
ETF 2
Advertisement
Diversification
FMED
Total weight of top 15 holdings out of 15
47.18%
ETF 2
–
Top 15 holdings
Data as of September 30, 2026
FMED
10X Genomics, Inc.
5.82%
Natera, Inc.
4.47%
Thermo Fisher Scientific, Inc.
4.19%
Danaher Corp.
3.92%
Illumina, Inc.
3.56%
argenx SE
2.96%
Lifestance Health Group, Inc.
2.87%
Revolution Medicines, Inc.
2.86%
Sartorius Stedim Biotech SA
2.72%
Moderna, Inc.
2.62%
Alnylam Pharmaceuticals, Inc.
2.48%
HeartFlow, Inc.
2.39%
Intuitive Surgical, Inc.
2.20%
Cogent Biosciences, Inc.
2.13%
Caris Life Sciences, Inc.
1.99%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
